Publications
Found 22 results
Filters: Author is J. Huang [Clear All Filters]
“Clinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy”, vol. 15, no. 4, p. -, 2016.
,
Conflicts of interest
The authors declare no conflict of interest.
ACKNOWLEDGMENTS
Research supported by the Capital Health Development Scientific Research Special Projects (#2011-1002-04) and the Capital Health Development and Scientific Research Projects (#2016-1-1113).
REFERENCES
Abalovich M, Amino N, Barbour LA, Cobin RH, et al (2007). Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 92 (Suppl): S1-S47. http://dx.doi.org/10.1210/jc.2007-0141
Casey BM, Dashe JS, Wells CE, McIntire DD, et al (2005). Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol. 105: 239-245. http://dx.doi.org/10.1097/01.AOG.0000152345.99421.22
Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, et al (2008). Maternal thyroid hypofunction and pregnancy outcome. Obstet. Gynecol. 112: 85-92. http://dx.doi.org/10.1097/AOG.0b013e3181788dd7
Chinese Society of Endocrinology and Chinese Society of Perinatal Medicineet al (2012). Guidelines for the diagnosis and treatment of thyroid disease in pregnancy and postpartum. Chin. J. Endocrinol. Metabol. 28: 354-371.
Gallas PR, Stolk RP, Bakker K, Endert E, et al (2002). Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. Eur. J. Endocrinol. 147: 443-451. http://dx.doi.org/10.1530/eje.0.1470443
Haddow JE, Palomaki GE, Allan WC, Williams JR, et al (1999). Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341: 549-555. http://dx.doi.org/10.1056/NEJM199908193410801
Helfand M, Redfern CC, American College of Physicianset al (1998). Clinical guideline, part 2. Screening for thyroid disease: an update. Ann. Intern. Med. 129: 144-158. http://dx.doi.org/10.7326/0003-4819-129-2-199807150-00020
Hollowell JGJrGarbePL, Miller DT, et al (1999). Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341: 2016-2017.
Lin L, Zhang XL, Long Y, et al (2014). Analysis of thyroid peroxidase antibody in early pregnancy. Genet. Mol. Res. 13: 5107-5114. http://dx.doi.org/10.4238/2014.July.7.3
Liu N, Bian XM, Gao YS, Qi H, et al (2009). Clinical analysis of hypothyroidism or subclinical hypothyroidism during pregnancy. Chin. J. Perinatal Med. 12: 186-189.
Negro R, Schwartz A, Gismondi R, Tinelli A, et al (2010). Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J. Clin. Endocrinol. Metab. 95: 1699-1707. http://dx.doi.org/10.1210/jc.2009-2009
Rovet JF, et al (1999). Congenital hypothyroidism: long-term outcome. Thyroid 9: 741-748. http://dx.doi.org/10.1089/thy.1999.9.741
Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartumet al (2011). Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21: 1081-1125. http://dx.doi.org/10.1089/thy.2011.0087
Wartofsky L, et al (2013). Combination L-T3 and L-T4 therapy for hypothyroidism. Curr. Opin. Endocrinol. Diabetes Obes. 20: 460-466. http://dx.doi.org/10.1097/01.med.0000432611.03732.49
Yu XH, Wang WW, Teng WP, Shan ZY, et al (2010). Levothyroxine treatment for subclinical hypothyroidism during pregnancy on the prospective study of the effect of offspring brain development. Chin. J. Endocrinol. Metab. 26: 921-925.
“Clinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy”, vol. 15, no. 4, p. -, 2016.
,
Conflicts of interest
The authors declare no conflict of interest.
ACKNOWLEDGMENTS
Research supported by the Capital Health Development Scientific Research Special Projects (#2011-1002-04) and the Capital Health Development and Scientific Research Projects (#2016-1-1113).
REFERENCES
Abalovich M, Amino N, Barbour LA, Cobin RH, et al (2007). Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 92 (Suppl): S1-S47. http://dx.doi.org/10.1210/jc.2007-0141
Casey BM, Dashe JS, Wells CE, McIntire DD, et al (2005). Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol. 105: 239-245. http://dx.doi.org/10.1097/01.AOG.0000152345.99421.22
Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, et al (2008). Maternal thyroid hypofunction and pregnancy outcome. Obstet. Gynecol. 112: 85-92. http://dx.doi.org/10.1097/AOG.0b013e3181788dd7
Chinese Society of Endocrinology and Chinese Society of Perinatal Medicineet al (2012). Guidelines for the diagnosis and treatment of thyroid disease in pregnancy and postpartum. Chin. J. Endocrinol. Metabol. 28: 354-371.
Gallas PR, Stolk RP, Bakker K, Endert E, et al (2002). Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. Eur. J. Endocrinol. 147: 443-451. http://dx.doi.org/10.1530/eje.0.1470443
Haddow JE, Palomaki GE, Allan WC, Williams JR, et al (1999). Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341: 549-555. http://dx.doi.org/10.1056/NEJM199908193410801
Helfand M, Redfern CC, American College of Physicianset al (1998). Clinical guideline, part 2. Screening for thyroid disease: an update. Ann. Intern. Med. 129: 144-158. http://dx.doi.org/10.7326/0003-4819-129-2-199807150-00020
Hollowell JGJrGarbePL, Miller DT, et al (1999). Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341: 2016-2017.
Lin L, Zhang XL, Long Y, et al (2014). Analysis of thyroid peroxidase antibody in early pregnancy. Genet. Mol. Res. 13: 5107-5114. http://dx.doi.org/10.4238/2014.July.7.3
Liu N, Bian XM, Gao YS, Qi H, et al (2009). Clinical analysis of hypothyroidism or subclinical hypothyroidism during pregnancy. Chin. J. Perinatal Med. 12: 186-189.
Negro R, Schwartz A, Gismondi R, Tinelli A, et al (2010). Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J. Clin. Endocrinol. Metab. 95: 1699-1707. http://dx.doi.org/10.1210/jc.2009-2009
Rovet JF, et al (1999). Congenital hypothyroidism: long-term outcome. Thyroid 9: 741-748. http://dx.doi.org/10.1089/thy.1999.9.741
Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartumet al (2011). Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21: 1081-1125. http://dx.doi.org/10.1089/thy.2011.0087
Wartofsky L, et al (2013). Combination L-T3 and L-T4 therapy for hypothyroidism. Curr. Opin. Endocrinol. Diabetes Obes. 20: 460-466. http://dx.doi.org/10.1097/01.med.0000432611.03732.49
Yu XH, Wang WW, Teng WP, Shan ZY, et al (2010). Levothyroxine treatment for subclinical hypothyroidism during pregnancy on the prospective study of the effect of offspring brain development. Chin. J. Endocrinol. Metab. 26: 921-925.
“Population structure analysis and association mapping of blast resistance in indica rice (Oryza sativa L.) landraces”, vol. 15, p. -, 2016.
, “Population structure analysis and association mapping of blast resistance in indica rice (Oryza sativa L.) landraces”, vol. 15, p. -, 2016.
, “Protective effect of the polarity of macrophages regulated by IL-37 on atherosclerosis”, vol. 15, p. -, 2016.
, “Protective effect of the polarity of macrophages regulated by IL-37 on atherosclerosis”, vol. 15, p. -, 2016.
, “Sequence analysis of peste des petits ruminants virus from ibexes in Xinjiang, China”, vol. 15, p. -, 2016.
, “Sequence analysis of peste des petits ruminants virus from ibexes in Xinjiang, China”, vol. 15, p. -, 2016.
, “Characterization of OsPM19L1 encoding an AWPM-19-like family protein that is dramatically induced by osmotic stress in rice”, vol. 14, pp. 11994-12005, 2015.
, “Complete mitochondrial genome of the Cyclemys dentata and phylogenetic analysis of the major family Geoemydidae”, vol. 14, pp. 3234-3243, 2015.
, “OsMYB511 encodes a MYB domain transcription activator early regulated by abiotic stress in rice”, vol. 14, pp. 9506-9517, 2015.
, , “Comprehensive gene expression analysis of the DNA (cytosine-5) methyltransferase family in rice (Oryza sativa L.)”, vol. 13, pp. 5159-5172, 2014.
, “Germline mutations of DICER1 in Chinese women with BRCA1/BRCA2-negative familial breast cancer”, vol. 13, pp. 10754-10760, 2014.
, “Predicting bacterial essential genes using only sequence composition information”, vol. 13, pp. 4564-4572, 2014.
, “Effect of erythropoietin on mesenchymal stem cell differentiation and secretion in vitro in an acute kidney injury microenvironment”, vol. 12, pp. 6477-6487, 2013.
, “Effect of IL-18 gene promoter polymorphisms on prostate cancer occurrence and prognosis in Han Chinese population”, vol. 12, pp. 820-829, 2013.
, Alexandrakis MG, Passam FH, Sfiridaki K, Moschandrea J, et al. (2004). Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival. Leuk. Res. 28: 259-266.
http://dx.doi.org/10.1016/S0145-2126(03)00261-3
Amin MA, Mansfield PJ, Pakozdi A, Campbell PL, et al. (2007). Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum. 56: 1787-1797.
http://dx.doi.org/10.1002/art.22705
PMid:17530707
Bushley AW, Ferrell R, McDuffie K, Terada KY, et al. (2004). Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol. Oncol. 95: 672-679.
http://dx.doi.org/10.1016/j.ygyno.2004.08.024
PMid:15581980
Charles AD (1999). Interleukin-18. Methods 19: 121-132.
http://dx.doi.org/10.1006/meth.1999.0837
PMid:10525448
Cho ML, Jung YO, Moon YM, Min SY, et al. (2006). Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol. Lett. 103: 159-166.
http://dx.doi.org/10.1016/j.imlet.2005.10.020
PMid:16368150
Desai KV, Michalowska AM, Kondaiah P, Ward JM, et al. (2004). Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate. Mol. Endocrinol. 18: 2895-2907.
http://dx.doi.org/10.1210/me.2004-0033
PMid:15358834
Dinarello CA (1999). IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103: 11-24.
http://dx.doi.org/10.1016/S0091-6749(99)70518-X
Eissa SA, Zaki SA, El-Maghraby SM and Kadry DY (2005). Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. J. Egypt. Natl. Canc. Inst. 17: 51-55.
PMid:16353083
Figg WD, Franks ME, Venzon D, Duray P, et al. (2004). Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer. World J. Urol. 22: 425-430.
http://dx.doi.org/10.1007/s00345-004-0443-7
PMid:15592675
Fujita K, Ewing CM, Sokoll LJ, Elliott DJ, et al. (2008). Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation. Prostate 68: 872-882.
http://dx.doi.org/10.1002/pros.20755
PMid:18361406 PMCid:2562260
Fujita K, Ewing CM, Isaacs WB and Pavlovich CP (2011). Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status. Int. J. Cancer 129: 424-432.
http://dx.doi.org/10.1002/ijc.25705
PMid:20878981 PMCid:3040782
Giedraitis V, He B, Huang WX and Hillert J (2001). Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J. Neuroimmunol. 112: 146-152.
http://dx.doi.org/10.1016/S0165-5728(00)00407-0
Gillies SD, Young D, Lo KM and Roberts S (1993). Biological activity and in vivo clearance of antitumor antibody/ cytokine fusion proteins. Bioconjug. Chem. 4: 230-235.
http://dx.doi.org/10.1021/bc00021a008
PMid:8324014
Han MY, Zheng S, Yu JM, Peng JP, et al. (2004). Study on interleukin-18 gene transfer into human breast cancer cells to prevent tumorigenicity. J. Zhejiang Univ. Sci. 5: 472-476.
http://dx.doi.org/10.1631/jzus.2004.0472
PMid:14994440
Jung MK, Song HK, Kim KE, Hur DY, et al. (2006). IL-18 enhances the migration ability of murine melanoma cells through the generation of ROI and the MAPK pathway. Immunol. Lett. 107: 125-130.
http://dx.doi.org/10.1016/j.imlet.2006.08.004
PMid:17014914
Kalina U, Ballas K, Koyama N, Kauschat D, et al. (2000). Genomic organization and regulation of the human interleukin-18 gene. Scand. J. Immunol. 52: 525-530.
http://dx.doi.org/10.1046/j.1365-3083.2000.00836.x
PMid:11119255
Kim KE, Song H, Kim TS, Yoon D, et al. (2007). Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines. Oncogene 26: 1468-1476.
http://dx.doi.org/10.1038/sj.onc.1209926
PMid:17001321
Lebel-Binay S, Thiounn N, De PG, Vieillefond A, et al. (2003). IL-18 is produced by prostate cancer cells and secreted in response to interferons. Int. J. Cancer 106: 827-835.
http://dx.doi.org/10.1002/ijc.11285
PMid:12918059
Li Z, Zhang Z, He Z, Tang W, et al. (2009). A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 19: 519-523.
http://dx.doi.org/10.1038/cr.2009.33
PMid:19290020
Liu J, Liu J, Zhou Y, Li S, et al. (2011). Association between promoter variants of interleukin-18 and schizophrenia in a Han Chinese population. DNA Cell Biol. 30: 913-917.
http://dx.doi.org/10.1089/dna.2011.1221
PMid:21510800
Liu Y, Lin N, Huang L, Xu Q, et al. (2007). Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer. DNA Cell Biol. 26: 613-618.
http://dx.doi.org/10.1089/dna.2007.0600
PMid:17688413
Marshall DJ, Rudnick KA, McCarthy SG, Mateo LR, et al. (2006). Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine 24: 244-253.
http://dx.doi.org/10.1016/j.vaccine.2005.07.087
PMid:16135392
Merendino RA, Gangemi S, Ruello A, Bene A, et al. (2001). Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations. Int. J. Biol. Markers 16: 126-129.
PMid:11471895
Okamura H, Tsutsi H, Komatsu T, Yutsudo M, et al. (1995). Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91.
http://dx.doi.org/10.1038/378088a0
PMid:7477296
Park H, Byun D, Kim TS, Kim YI, et al. (2001). Enhanced IL-18 expression in common skin tumors. Immunol. Lett. 79: 215-219.
http://dx.doi.org/10.1016/S0165-2478(01)00278-4
Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, et al. (2006). Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol. Immunother. 55: 23-30.
http://dx.doi.org/10.1007/s00262-005-0688-z
PMid:16059673
Shi YY and He L (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15: 97-98.
http://dx.doi.org/10.1038/sj.cr.7290272
PMid:15740637
Stacey SN, Sulem P, Jonasdottir A, Masson G, et al. (2011). A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat. Genet. 43: 1098-1103.
http://dx.doi.org/10.1038/ng.926
PMid:21946351 PMCid:3263694
Takagawa T, Tamura K, Takeda N, Tomita T, et al. (2005). Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflamm. Bowel. Dis. 11: 1038-1043.
http://dx.doi.org/10.1097/01.MIB.0000182868.67025.b9
PMid:16306765
Tse BW, Russell PJ, Lochner M, Förster I, et al. (2011). IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms. PLoS One 6: e24241.
http://dx.doi.org/10.1371/journal.pone.0024241
PMid:21935389 PMCid:3174151
Wang F, Zou YF, Feng XL, Su H, et al. (2011). CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies. Prostate 71: 1167-1177.
http://dx.doi.org/10.1002/pros.21332
Wentzensen N, Black A, Jacobs K, Yang HP, et al. (2011). Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the prostate, lung, colorectal, and ovarian cancer screening trial. PLoS One 6: e21731.
http://dx.doi.org/10.1371/journal.pone.0021731
PMid:21750727 PMCid:3131287
Xia D, Li F and Xiang J (2004). Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity. Cancer Biother. Radiopharm. 19: 322-330.
http://dx.doi.org/10.1089/1084978041424990
PMid:15285878
Ye ZB, Ma T, Li H, Jin XL, et al. (2007). Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J. Gastroenterol. 13: 1747-1751.
PMid:17461482
Yoon- DY, Cho YS, Park JW, Kim SH, et al. (2004). Up-regulation of reactive oxygen species (ROS) and resistance to Fas-mediated apoptosis in the C33A cervical cancer cell line transfected with IL-18 receptor. Clin. Chem. Lab. Med. 42: 499-506.
PMid:15202785
Zeegers MP, Khan HS, Schouten LJ, van Dijk BA, et al. (2011). Genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population: DG8S737 may not be the causative variant. Eur. J. Hum. Genet. 19: 118-120.
http://dx.doi.org/10.1038/ejhg.2010.133
PMid:20700145 PMCid:3039500
Zhou W, Chen Z, Hu W, Shen M, et al. (2011). Association of short tandem repeat polymorphism in the promoter of prostate cancer antigen 3 gene with the risk of prostate cancer. PLoS One 6: e20378.
http://dx.doi.org/10.1371/journal.pone.0020378
PMid:21655300 PMCid:3105025
“Wilms' tumor suppressor gene mutations in girls with sporadic isolated steroid-resistant nephrotic syndrome”, vol. 12, pp. 6184-6191, 2013.
, “Co-evolution of genomic islands and their bacterial hosts revealed through phylogenetic analyses of 17 groups of homologous genomic islands”, vol. 11, pp. 3735-3743, 2012.
,
Chu KH, Qi J, Yu Z-G and Anh V (2004). Origin and phylogeny of chloroplasts revealed by a simple correlation analysis of complete genomes. Mol. Biol. Evol. 21: 200-206.
http://dx.doi.org/10.1093/molbev/msh002
PMid:14595102
Dobrindt U, Hochhut B, Hentschel U and Hacker J (2004). Genomic islands in pathogenic and environmental microorganisms. Nat. Rev. Microbiol. 2: 414-424.
http://dx.doi.org/10.1038/nrmicro884
PMid:15100694
Doolittle WF (1999). Phylogenetic classification and the universal tree. Science 284: 2124-2129.
http://dx.doi.org/10.1126/science.284.5423.2124
PMid:10381871
Gao L, Qi J, Wei H, Sun Y, et al. (2003). Molecular phylogeny of coronaviruses including human SARS-CoV. Chin. Sci. Bull. 48: 1170-1174.
Garcia-Vallvé S, Romeu A and Palau J (2000). Horizontal gene transfer in bacterial and archaeal complete genomes. Genome Res. 10: 1719-1725.
http://dx.doi.org/10.1101/gr.130000
PMid:11076857 PMCid:310969
Garcia-Vallvé S, Guzman E, Montero MA and Romeu A (2003). HGT-DB: a database of putative horizontally transferred genes in prokaryotic complete genomes. Nucleic Acids Res. 31: 187-189.
http://dx.doi.org/10.1093/nar/gkg004
PMid:12519978 PMCid:165451
Gascuel O (1997). BIONJ: an improved version of the NJ algorithm based on a simple model of sequence data. Mol. Biol. Evol. 14: 685-695.
http://dx.doi.org/10.1093/oxfordjournals.molbev.a025808
PMid:9254330
Gogarten JP and Townsend JP (2005). Horizontal gene transfer, genome innovation and evolution. Nat. Rev. Microbiol. 3: 679-687.
http://dx.doi.org/10.1038/nrmicro1204
PMid:16138096
Hacker J and Kaper JB (2000). Pathogenicity islands and the evolution of microbes. Annu. Rev. Microbiol. 54: 641-679.
http://dx.doi.org/10.1146/annurev.micro.54.1.641
PMid:11018140
Hacker J and Carniel E (2001). Ecological fitness, genomic islands and bacterial pathogenicity. A Darwinian view of the evolution of microbes. EMBO Rep. 2: 376-381.
PMid:11375927 PMCid:1083891
Hentschel U and Hacker J (2001). Pathogenicity islands: the tip of the iceberg. Microbes Infect. 3: 545-548.
http://dx.doi.org/10.1016/S1286-4579(01)01410-1
Ho Sui SJ, Fedynak A, Hsiao WW, Langille MG, et al. (2009). The association of virulence factors with genomic islands. PLoS One 4: e8094.
http://dx.doi.org/10.1371/journal.pone.0008094
PMid:19956607 PMCid:2779486
Juhas M, van der Meer JR, Gaillard M, Harding RM, et al. (2009). Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol. Rev. 33: 376-393.
http://dx.doi.org/10.1111/j.1574-6976.2008.00136.x
PMid:19178566 PMCid:2704930
Jun SR, Sims GE, Wu GA and Kim SH (2010). Whole-proteome phylogeny of prokaryotes by feature frequency profiles: An alignment-free method with optimal feature resolution. Proc. Natl. Acad. Sci. U. S. A. 107: 133-138.
http://dx.doi.org/10.1073/pnas.0913033107
PMid:20018669 PMCid:2806744
Keeling PJ and Palmer JD (2008). Horizontal gene transfer in eukaryotic evolution. Nat. Rev. Genet. 9: 605-618.
http://dx.doi.org/10.1038/nrg2386
PMid:18591983
Langille MG, Hsiao WW and Brinkman FS (2008). Evaluation of genomic island predictors using a comparative genomics approach. BMC Bioinformatics 9: 329.
http://dx.doi.org/10.1186/1471-2105-9-329
PMid:18680607 PMCid:2518932
Langille MG, Hsiao WW and Brinkman FS (2010). Detecting genomic islands using bioinformatics approaches. Nat. Rev. Microbiol. 8: 373-382.
http://dx.doi.org/10.1038/nrmicro2350
PMid:20395967
Lawrence JG (1999). Gene transfer, speciation, and the evolution of bacterial genomes. Curr. Opin. Microbiol. 2: 519-523.
http://dx.doi.org/10.1016/S1369-5274(99)00010-7
Lawrence JG and Ochman H (1997). Amelioration of bacterial genomes: rates of change and exchange. J. Mol. Evol. 44: 383-397.
http://dx.doi.org/10.1007/PL00006158
PMid:9089078
Nakamura Y, Itoh T, Matsuda H and Gojobori T (2004). Biased biological functions of horizontally transferred genes in prokaryotic genomes. Nat. Genet. 36: 760-766.
http://dx.doi.org/10.1038/ng1381
PMid:15208628
Ochman H, Lawrence JG and Groisman EA (2000). Lateral gene transfer and the nature of bacterial innovation. Nature 405: 299-304.
http://dx.doi.org/10.1038/35012500
PMid:10830951
Pennisi E (1998). Genome data shake tree of life. Science 280: 672-674.
http://dx.doi.org/10.1126/science.280.5364.672
PMid:9599142
Qi J, Wang B and Hao BI (2004). Whole proteome prokaryote phylogeny without sequence alignment: a K-string composition approach. J. Mol. Evol. 58: 1-11.
http://dx.doi.org/10.1007/s00239-003-2493-7
PMid:14743310
Sims GE and Kim SH (2011). Whole-genome phylogeny of Escherichia coli/Shigella group by feature frequency profiles (FFPs). Proc. Natl. Acad. Sci. U. S. A. 108: 8329-8334.
http://dx.doi.org/10.1073/pnas.1105168108
PMid:21536867 PMCid:3100984
Sims GE, Jun SR, Wu GA and Kim SH (2009a). Alignment-free genome comparison with feature frequency profiles (FFP) and optimal resolutions. Proc. Natl. Acad. Sci. U. S. A. 106: 2677-2682.
http://dx.doi.org/10.1073/pnas.0813249106
PMid:19188606 PMCid:2634796
Sims GE, Jun SR, Wu GA and Kim SH (2009b). Whole-genome phylogeny of mammals: evolutionary information in genic and nongenic regions. Proc. Natl. Acad. Sci. U. S. A. 106: 17077-17082.
http://dx.doi.org/10.1073/pnas.0909377106
PMid:19805074 PMCid:2761373
Tamura K, Dudley J, Nei M and Kumar S (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24: 1596-1599.
http://dx.doi.org/10.1093/molbev/msm092
PMid:17488738
Touzain F, Denamur E, Medigue C, Barbe V, et al. (2010). Small variable segments constitute a major type of diversity of bacterial genomes at the species level. Genome Biol. 11: R45.
http://dx.doi.org/10.1186/gb-2010-11-4-r45
PMid:20433696 PMCid:2884548
Vernikos GS and Parkhill J (2006). Interpolated variable order motifs for identification of horizontally acquired DNA: revisiting the Salmonella pathogenicity islands. Bioinformatics 22: 2196-2203.
http://dx.doi.org/10.1093/bioinformatics/btl369
PMid:16837528
Wolf YI, Rogozin IB, Grishin NV, Tatusov RL, et al. (2001). Genome trees constructed using five different approaches suggest new major bacterial clades. BMC Evol. Biol. 1: 8.
http://dx.doi.org/10.1186/1471-2148-1-8
PMid:11734060 PMCid:60490
Wolf YI, Rogozin IB, Grishin NV and Koonin EV (2002). Genome trees and the tree of life. Trends Genet. 18: 472-479.
http://dx.doi.org/10.1016/S0168-9525(02)02744-0
Wu GA, Jun SR, Sims GE and Kim SH (2009). Whole-proteome phylogeny of large dsDNA virus families by an alignment-free method. Proc. Natl. Acad. Sci. U. S. A. 106: 12826-12831.
http://dx.doi.org/10.1073/pnas.0905115106
PMid:19553209 PMCid:2722272
Xu Z and Hao B (2009). CVTree update: a newly designed phylogenetic study platform using composition vectors and whole genomes. Nucleic Acids Res. 37: W174-W178.
http://dx.doi.org/10.1093/nar/gkp278
PMid:19398429 PMCid:2703908
Yoon SH, Hur CG, Kang HY, Kim YH, et al. (2005). A computational approach for identifying pathogenicity islands in prokaryotic genomes. BMC Bioinformatics 6: 184.
http://dx.doi.org/10.1186/1471-2105-6-184
PMid:16033657 PMCid:1188055
Yoon SH, Park YK, Lee S, Choi D, et al. (2007). Towards pathogenomics: a web-based resource for pathogenicity islands. Nucleic Acids Res. 35: D395-D400.
http://dx.doi.org/10.1093/nar/gkl790
PMid:17090594 PMCid:1669727
“Mutations in NPHS1 in a Chinese child with congenital nephrotic syndrome”, vol. 11, pp. 1460-1464, 2012.
,
Aya K, Tanaka H and Seino Y (2000). Novel mutation in the nephrin gene of a Japanese patient with congenital nephrotic syndrome of the Finnish type. Kidney Int. 57: 401-404.
http://dx.doi.org/10.1046/j.1523-1755.2000.00859.x
PMid:10652016
Heeringa SF, Vlangos CN, Chernin G, Hinkes B, et al. (2008). Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome. Nephrol. Dial. Transplant. 23: 3527-3533.
http://dx.doi.org/10.1093/ndt/gfn271
PMid:18503012 PMCid:2720813
Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, et al. (2007). Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119: e907-e919.
http://dx.doi.org/10.1542/peds.2006-2164
PMid:17371932
Ismaili K, Pawtowski A, Boyer O, Wissing KM, et al. (2009). Genetic forms of nephrotic syndrome: a single-center experience in Brussels. Pediatr. Nephrol. 24: 287-294.
http://dx.doi.org/10.1007/s00467-008-0953-4
PMid:18709391
Jalanko H (2009). Congenital nephrotic syndrome. Pediatr. Nephrol. 24: 2121-2128.
http://dx.doi.org/10.1007/s00467-007-0633-9
PMid:17968594 PMCid:2753773
Kestilä M, Lenkkeri U, Mannikko M, Lamerdin J, et al. (1998). Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol. Cell 1: 575-582.
http://dx.doi.org/10.1016/S1097-2765(00)80057-X
Lahdenkari AT, Kestila M, Holmberg C, Koskimies O, et al. (2004). Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS). Kidney Int. 65: 1856-1863.
http://dx.doi.org/10.1111/j.1523-1755.2004.00583.x
PMid:15086927
Lee BH, Ahn YH, Choi HJ, Kang HK, et al. (2009). Two Korean infants with genetically confirmed congenital nephrotic syndrome of Finnish type. J. Korean Med. Sci. 24 (Suppl 1): S210-S214.
http://dx.doi.org/10.3346/jkms.2009.24.S1.S210
PMid:19194555 PMCid:2633182
Lenkkeri U, Mannikko M, McCready P, Lamerdin J, et al. (1999). Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am. J. Hum. Genet. 64: 51-61.
http://dx.doi.org/10.1086/302182
PMid:9915943 PMCid:1377702
Pätäri-Sampo A, Ihalmo P and Holthofer H (2006). Molecular basis of the glomerular filtration: nephrin and the emerging protein complex at the podocyte slit diaphragm. Ann. Med. 38: 483-492.
http://dx.doi.org/10.1080/07853890600978149
PMid:17101539
Santín S, Garcia-Maset R, Ruiz P, Gimenez I, et al. (2009). Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis. Kidney Int. 76: 1268-1276.
http://dx.doi.org/10.1038/ki.2009.381
PMid:19812541
Schoeb DS, Chernin G, Heeringa SF, Matejas V, et al. (2010). Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS). Nephrol. Dial. Transplant. 25: 2970-2976.
http://dx.doi.org/10.1093/ndt/gfq088
PMid:20172850 PMCid:2948833
Shi Y, Ding J, Liu JC, Wang H, et al. (2005). NPHS1 mutations in a Chinese family with congenital nephrotic syndrome. Zhonghua Er Ke Za Zhi 43: 805-809.
PMid:16316524
Wu LQ, Hu JJ, Xue JJ and Liang DS (2011). Two novel NPHS1 mutations in a Chinese family with congenital nephrotic syndrome. Genet. Mol. Res. 10: 2517-2522.
http://dx.doi.org/10.4238/2011.October.18.1
PMid:22009864
“Regulation of ATG6/Beclin-1 homologs by abiotic stresses and hormones in rice (Oryza sativa L.)”, vol. 11, pp. 3676-3687, 2012.
,
Cao Y and Klionsky DJ (2007). Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 17: 839-849.
http://dx.doi.org/10.1038/cr.2007.78
PMid:17893711
Chen X, Gu Z, Xin D, Hao L, et al. (2011). Identification and characterization of putative CIPK genes in maize. J. Genet. Genom. 38: 77-87.
http://dx.doi.org/10.1016/j.jcg.2011.01.005
PMid:21356527
Fujiki Y, Yoshimoto K and Ohsumi Y (2007). An Arabidopsis homolog of yeast ATG6/VPS30 is essential for pollen germination. Plant Physiol. 143: 1132-1139.
http://dx.doi.org/10.1104/pp.106.093864
PMid:17259285 PMCid:1820928
Gu X and Vander Velden K (2002). DIVERGE: phylogeny-based analysis for functional-structural divergence of a protein 3687 Regulation of ATG6 homologs by abiotic stresses and hormones family. Bioinformatics 18: 500-501.
http://dx.doi.org/10.1093/bioinformatics/18.3.500
PMid:11934757
Harrison-Lowe NJ and Olsen LJ (2008). Autophagy protein 6 (ATG6) is required for pollen germination in Arabidopsis thaliana. Autophagy 4.
Hashiguchi Y, Furuta Y, Kawahara R and Nishida M (2007). Diversification and adaptive evolution of putative sweet taste receptors in threespine stickleback. Gene 396: 170-179.
http://dx.doi.org/10.1016/j.gene.2007.03.015
PMid:17467198
Horton P, Park KJ, Obayashi T and Nakai K (2006). Protein Subcellular Localization Prediction with WoLF PSORT. Citeseer.
Huang J, Wang MM, Bao YM, Sun SJ, et al. (2008). SRWD: a novel WD40 protein subfamily regulated by salt stress in rice (Oryza sativa L.). Gene 424: 71-79.
http://dx.doi.org/10.1016/j.gene.2008.07.027
PMid:18755256
Hung KT and Kao CH (2004). Hydrogen peroxide is necessary for abscisic acid-induced senescence of rice leaves. J. Plant Physiol. 161: 1347-1357.
http://dx.doi.org/10.1016/j.jplph.2004.05.011
PMid:15658805
Jung KH, Dardick C, Bartley LE, Cao P, et al. (2008). Refinement of light-responsive transcript lists using rice oligonucleotide arrays: evaluation of gene-redundancy. PLoS One 3: e3337.
http://dx.doi.org/10.1371/journal.pone.0003337
PMid:18836531 PMCid:2556097
Kametaka S, Okano T, Ohsumi M and Ohsumi Y (1998). Apg14p and Apg6/Vps30p form a protein complex essential for autophagy in the yeast, Saccharomyces cerevisiae. J. Biol. Chem. 273: 22284-22291.
http://dx.doi.org/10.1074/jbc.273.35.22284
PMid:9712845
Liu Y, Schiff M, Czymmek K, Talloczy Z, et al. (2005). Autophagy regulates programmed cell death during the plant innate immune response. Cell 121: 567-577.
http://dx.doi.org/10.1016/j.cell.2005.03.007
PMid:15907470
Meng XB, Zhao WS, Lin RM, Wang M, et al. (2006). Molecular cloning and characterization of a rice blast-inducible RING-H2 type zinc finger gene. DNA Seq. 17: 41-48.
http://dx.doi.org/10.1080/10425170500476509
PMid:16753816
Michiorri S, Gelmetti V, Giarda E, Lombardi F, et al. (2010). The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death. Differ. 17: 962-974.
http://dx.doi.org/10.1038/cdd.2009.200
PMid:20057503
Mochida K, Kawaura K, Shimosaka E, Kawakami N, et al. (2006). Tissue expression map of a large number of expressed sequence tags and its application to in silico screening of stress response genes in common wheat. Mol. Genet. Genom. 276: 304-312.
http://dx.doi.org/10.1007/s00438-006-0120-1
PMid:16832693
Moriyasu Y and Ohsumi Y (1996). Autophagy in tobacco suspension-cultured cells in response to sucrose starvation. Plant Physiol. 111: 1233-1241.
PMid:12226358 PMCid:161001
Nielsen R and Yang Z (1998). Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148: 929-936.
PMid:9539414 PMCid:1460041
Qin G, Ma Z, Zhang L, Xing S, et al. (2007). Arabidopsis AtBECLIN 1/AtAtg6/AtVps30 is essential for pollen germination and plant development. Cell Res. 17: 249-263.
PMid:17339883
Ramalingam J, Pathan MS, Feril O, Ross K, et al. (2006). Structural and functional analyses of the wheat genomes based on expressed sequence tags (ESTs) related to abiotic stresses. Genome 49: 1324-1340.
http://dx.doi.org/10.1139/g06-094
PMid:17218960
Rana RM, Dong S, Ali Z, Khan AI, et al. (2012). Identification and characterization of the Bcl-2-associated athanogene (BAG) protein family in rice. Afr. J. Biotechnol. 11: 88-99.
Sato Y and Yokoya S (2008). Enhanced tolerance to drought stress in transgenic rice plants overexpressing a small heat-shock protein, sHSP17.7. Plant Cell Rep. 27: 329-334.
http://dx.doi.org/10.1007/s00299-007-0470-0
PMid:17968552
Sinha S and Levine B (2008). The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 27 (Suppl 1): S137-S148.
http://dx.doi.org/10.1038/onc.2009.51
PMid:19641499 PMCid:2731580
Suzuki K, Kirisako T, Kamada Y, Mizushima N, et al. (2001). The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J. 20: 5971-5981.
http://dx.doi.org/10.1093/emboj/20.21.5971
PMid:11689437 PMCid:125692
Tamura K, Peterson D, Peterson N, Stecher G, et al. (2011). MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28: 2731-2739.
http://dx.doi.org/10.1093/molbev/msr121
PMid:21546353 PMCid:3203626
Thompson JD, Higgins DG and Gibson TJ (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 4673-4680.
http://dx.doi.org/10.1093/nar/22.22.4673
PMid:7984417 PMCid:308517
Waterhouse AM, Procter JB, Martin DM, Clamp M, et al. (2009). Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25: 1189-1191.
http://dx.doi.org/10.1093/bioinformatics/btp033
PMid:19151095 PMCid:2672624
Wolfe KH, Gouy M, Yang YW, Sharp PM, et al. (1989). Date of the monocot-dicot divergence estimated from chloroplast DNA sequence data. Proc. Natl. Acad. Sci. U. S. A. 86: 6201-6205.
http://dx.doi.org/10.1073/pnas.86.16.6201
PMid:2762323 PMCid:297805
Wu S, Yu Z, Wang F, Li W, et al. (2007). Cloning, characterization, and transformation of the phosphoethanolamine N-methyltransferase gene (ZmPEAMT1) in maize (Zea mays L.). Mol. Biotechnol. 36: 102-112.
http://dx.doi.org/10.1007/s12033-007-0009-1
PMid:17914189
Xia K, Liu T, Ouyang J, Wang R, et al. (2011). Genome-wide identification, classification, and expression analysis of autophagy-associated gene homologues in rice (Oryza sativa L.). DNA Res. 18: 363-377.
http://dx.doi.org/10.1093/dnares/dsr024
PMid:21795261 PMCid:3190957
Yang Z (2007). PAML 4: phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 24: 1586-1591.
http://dx.doi.org/10.1093/molbev/msm088
PMid:17483113
Yang Z and Nielsen R (2002). Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages. Mol. Biol. Evol. 19: 908-917.
http://dx.doi.org/10.1093/oxfordjournals.molbev.a004148
PMid:12032247
Yang Z, Nielsen R, Goldman N and Pedersen AM (2000). Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155: 431-449.
PMid:10790415 PMCid:1461088
“Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression”, vol. 11, pp. 77-86, 2012.
, Adams LS, Phung S, Yee N, Seeram NP, et al. (2010). Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res. 70: 3594-3605.
http://dx.doi.org/10.1158/0008-5472.CAN-09-3565
PMid:20388778 PMCid:2862148
Baneshi MR, Warner P, Anderson N, Edwards J, et al. (2010). Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction. Br. J. Cancer 102: 1503-1510.
http://dx.doi.org/10.1038/sj.bjc.6605627
PMid:20461093 PMCid:2869158
Blaheta RA, Nau H, Michaelis M and Cinatl J Jr (2002). Valproate and valproate-analogues: potent tools to fight against cancer. Curr. Med. Chem. 9: 1417-1433.
PMid:12173980
Byun SS, Kim FJ, Khandrika L, Kumar B, et al. (2009). Differential effects of valproic acid on growth, proliferation and metastasis in HTB5 and HTB9 bladder cancer cell lines. Cancer Lett. 281: 196-202.
http://dx.doi.org/10.1016/j.canlet.2009.02.045
PMid:19324494
Chen PS, Wang CC, Bortner CD, Peng GS, et al. (2007). Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 149: 203- 212.
http://dx.doi.org/10.1016/j.neuroscience.2007.06.053
PMid:17850978 PMCid:2741413
D’Angelo A, Garzia L, Andre A, Carotenuto P, et al. (2004). Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer Cell 5: 137-149.
http://dx.doi.org/10.1016/S1535-6108(04)00021-2
D’Souza A, Onem E, Patel P, La Gamma EF, et al. (2009). Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation. Brain Res. 1247: 1-10.
http://dx.doi.org/10.1016/j.brainres.2008.09.088
PMid:18976638
Dragunow M, Greenwood JM, Cameron RE, Narayan PJ, et al. (2006). Valproic acid induces caspase 3-mediated apoptosis in microglial cells. Neuroscience 140: 1149-1156.
http://dx.doi.org/10.1016/j.neuroscience.2006.02.065
PMid:16600518
Duenas-Gonzalez A, Candelaria M, Perez-Plascencia C, Perez-Cardenas E, et al. (2008). Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat. Rev. 34: 206-222.
http://dx.doi.org/10.1016/j.ctrv.2007.11.003
PMid:18226465
Dutertre M, Gratadou L, Dardenne E, Germann S, et al. (2010). Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer. Cancer Res. 70: 3760-3770.
http://dx.doi.org/10.1158/0008-5472.CAN-09-3988
PMid:20406972
Fortunati N, Bertino S, Costantino L, Bosco O, et al. (2008). Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells. Cancer Lett. 259: 156-164.
http://dx.doi.org/10.1016/j.canlet.2007.10.006
PMid:18006146
Jawed S, Kim B, Ottenhof T, Brown GM, et al. (2007). Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. Eur. J. Pharmacol. 560: 17-22.
http://dx.doi.org/10.1016/j.ejphar.2007.01.022
PMid:17303109
Jin L, Liu G, Zhang CH, Lu CH, et al. (2009). Nm23-H1 regulates the proliferation and differentiation of the human chronic myeloid leukemia K562 cell line: a functional proteomics study. Life Sci. 84: 458-467.
http://dx.doi.org/10.1016/j.lfs.2009.01.010
PMid:19302816
Lagneaux L, Gillet N, Stamatopoulos B, Delforge A, et al. (2007). Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Exp. Hematol. 35: 1527-1537.
http://dx.doi.org/10.1016/j.exphem.2007.06.014
PMid:17697742
Leone A, McBride OW, Weston A, Wang MG, et al. (1991). Somatic allelic deletion of nm23 in human cancer. Cancer Res. 51: 2490-2493.
PMid:2015608
Liang M, Zhang P and Fu J (2007). Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett. 258: 31-37.
http://dx.doi.org/10.1016/j.canlet.2007.08.003
PMid:17868983
Marshall SF, Clarke CA, Deapen D, Henderson K, et al. (2010). Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort. Breast Cancer Res. 2: R4.
http://dx.doi.org/10.1186/bcr2467
PMid:20064209 PMCid:2880422
Platta CS, Greenblatt DY, Kunnimalaiyaan M and Chen H (2008). Valproic acid induces Notch1 signaling in small cell lung cancer cells. J Surg. Res. 148: 31-37.
http://dx.doi.org/10.1016/j.jss.2008.03.008
PMid:18570928 PMCid:2900385
Shen WT, Wong TS, Chung WY, Wong MG, et al. (2005). Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells. Surgery 138: 979-984.
http://dx.doi.org/10.1016/j.surg.2005.09.019
PMid:16360381
Swain SM, Jeong JH, Geyer CE Jr, Costantino JP, et al. (2010). Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N. Engl. J. Med. 362: 2053-2065.
http://dx.doi.org/10.1056/NEJMoa0909638
PMid:20519679 PMCid:2935316
Wu L, Li Z, Zhang Y, Zhang P, et al. (2008). Adenovirus-expressed human hyperpla- sia suppressor gene induces apoptosis in cancer cells. Mol. Cancer Ther. 7: 222-232.
http://dx.doi.org/10.1158/1535-7163.MCT-07-0382
PMid:18202024